AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Tharimmune, Inc. Director's Dealing 2022

Jan 20, 2022

34824_dirs_2022-01-20_a5cb3561-8d37-452a-97e3-838791b0f681.zip

Director's Dealing

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: Hillstream BioPharma Inc. (HILS)
CIK: 0001861657
Period of Report: 2022-01-11

Reporting Person: MILBY RANDY (Director, Chief Executive Officer, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock	1772725	Direct

Footnotes

F1: These shares were omitted from the Reporting Person's original Form 3.